Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer
Pituitary, 10/29/09
Guerra Y et al. – The authors report the case of a 60 year old male who complained of headache and blurry vision—that progressed to left ophthalmoplegia and ptosis—after receiving a dose of leuprolide for Prostate cancer therapy. Imaging showed a hemorrhagic sellar mass. Particular attention to clinical findings suggestive of a non functioning pituitary tumor in patients receiving GnRH agonist therapy is critical as routine screening with MRI is not practical.
Related Articles
Signalling Pathway Alterations in Pituitary Adenomas: Involvement of Gsalpha, cAMP and Mitogen-Activated Protein Kinases
Journal of Neuroendocrinology, 11/03/09
Relevance Score: 68%
Regulation of Pituitary Function by Cytokines
Hormone Research, 10/27/09
Relevance Score: 67%
Pituitary metastasis of Merkel cell carcinoma
Journal of Neuro-Oncology, 10/28/09
Relevance Score: 66%
Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Relevance Score: 66%
The natural history of surgically treated but radiotherapy-naive nonfunctioning pituitary adenomas
Clinical Endocrinology, 10/15/09
Relevance Score: 65%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Administration of connexin43 siRNA abolishes secretory pulse synchronization in GnRH clonal cell populations
Molecular and Cellular Endocrinology, 11/24/09
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/24/09
Effectiveness of the Combined Recombinant Human Growth Hormone and Gonadotropin-Releasing Hormone Analog Therapy in Pubertal Patients with Short Stature due to SHOX Deficiency
Journal of Clinical Endocrinology and Metabolism, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


